Control of Endogenous Mouse Mammary Tumor Virus Superantigen Expression in SJL Lymphomas by a Promoter Within the env Region

Journal of Immunology

Volumn 157, Issue 8, 1996, Pages 3510-3517

  Zhang, Da Jun ^a   Tsiagbe, Vincent K ^a   Huang, Ching ^a   Thorbecke, G Jeanette ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PRIMER DNA; RNA; SUPERANTIGEN; VIRUS RNA;

AKR MOUSE; ANIMAL; ARTICLE; ENVELOPE GENE; FEMALE; GENETIC TRANSCRIPTION; GENETICS; HISTIOCYTIC LYMPHOMA; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROVIRUS; VIROLOGY;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; DNA, COMPLEMENTARY; FEMALE; GENES, ENV; LYMPHOMA, LARGE-CELL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED AKR; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); PROVIRUSES; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; RNA, NEOPLASM; RNA, VIRAL; SUPERANTIGENS; TRANSCRIPTION, GENETIC;

EID: 0030587854     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Tsiagbe, V. K., T. Yoshimoto, J. Asakawa, S. Y. Cho, D. Meruelo, and G. J. Thorbecke. 1993. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 12:2313.
2. Zhang, D. J., P. D'Eustachio, and G. J. Thorbecke. 1996. The mtv29 gene encoding endogenous lymphoma superantigen in SJL mice, mapped to proximal chromosome 6. Immunogenetics. In press.
3. Ponzio, N. M., P. H. Brown, and G. J. Thorbecke. 1986. Host-tumor interactions in the SJL lymphoma model. Int. Rev. Immunol. 1:273.
4. + T cells. J. Immunol. 150:5519.
5. Wheeler, D. A., J. S. Butel, D. Medina, R. D. Cardiff, and G. L. Hager. 1983. Transcription of mouse tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J. Virol. 46:42.
6. Van Doyen, A. J. J., R. J. A. M. Michalides, and R. Nusse. 1983. Structural analysis of a 1.7 kb mouse mammary tumor virus-specific RNA. J. Virol. 46:362.
7. King, L. B., F. E. Lund, D. A. White, S. Sharma, and R. B. Corley. 1990. Molecular events in B lymphocyte differentiation: inducible expression of the endogenous mouse mammary tumor proviral gene, Mtv-9. J. Immunol. 144:3218.
8. Lund, F. E., and R. B. Corley. 1991. Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage. J. Exp. Med. 174:1439.
9. Beutner, U., W. N. Frankel, M. S. Cote, J. M. Coffin, and B. T. Huber. 1992. Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc. Natl. Acad. Sci. USA 89:5432.
10. Waanders, G. A., R. K. Lees, W. Held, and H. R. MacDonald. 1995. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets. Eur. J. Immunol. 25:2632.
11. Sen, G. C., S. W. Smith, S. L. Marcus, and N. H. Sarkar. 1979. Identification of the messenger RNAs coding for the gag and env gene products of the murine mammary tumor virus. Proc. Natl. Acad. Sci. USA 76:1736.
12. Gunzburg, W. H., F. Heinemann, S. Winstersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364:154.
13. Ball, J. K., H. Diggelmann, G. A. Dekaban, G. F. Grossi, R. Semmler, P. A. Waight, and R. F. Fletcher. 1988. Alterations in the U3 region of the long terminal repeat of an infectious thymotropic type B retrovirus. J. Virol. 62:2985.
14. Dudley, J. P., A. Arfsten, C.-L. L. Hsu, C. Kozak, and R. Risser. 1986. Molecular cloning and characterization of mouse mammary tumor provirus from a T-cell lymphoma. J. Virol. 57:385.
15. Michalides, R., E. Wagenaar, and P. Weijers. 1985. Rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in T-cell leukemias of mouse strain GR result in a novel enhancer-like structure. Mol. Cell. Biol. 5:823.
16. Hsu, C.-L. L., C. Fabritius, and J. Dudley. 1988. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J. Virol. 62:4644.
17. Morley, K. L., M. G. Toohey, and D. O. Peterson. 1987. Transcriptional repression of a hormone-responsive promoter. Nucleic Acids Res. 15:6973.
18. Bramblett, D., C.-L. L. Hsu, M. Lozano, K. Earnest, C. Fabritius, and J. Dudley. 1995. A redundant nuclear protein binding site contributes to a negative regulation of the mouse mammary tumor virus long terminal repeat. J. Virol. 69:7868.
19. Miller, C. L., R. Gamer, and V. Paetkau. 1992. An activation-dependent, T-lymphocyte specific transcriptional activator in the mouse mammary tumor virus env gene. Mol. Cell. Biol. 12:3262.
20. Elliott, J. F., B. Pohajdak, D. J. Talbot, J. Shaw, and V. Paetkau. 1988. Phorbol diester-inducible, cyclosporine-supressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J. Virol. 62:1373.
21. Dyson, P. J., A. M. Knight, S. Fairchild, E. Simpson, and K. Tomonari. 1991. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature 349:531.
22. Lasky, J. L., N. M. Ponzio, and G. T. Thorbecke. 1988. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X. J. Immunol. 14:679.
23. Tsiagbe, V. K., J. Asakawa, N. M. Ponzio, and G. J. Thorbecke. 1990. Paraproteins and primary lymphoma in SJL mice. II. Primary lymphomas do not produce paraprotein. Cell. Immunol. 129:503.
24. + B cell lymphoma arising in a CD4 monoclonal antibody-treated SJL mouse. Clin. Immunol. Immunopathol. 65:10.
25. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
26. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156.
27. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463.
28. Pearson, W. R., and D. J. Lipman. 1988. Improved tools for biological sequence comparison. Proc. Natl. Acad. Sci. USA 85:2444.
29. Sambrook, J., E. F. Frilch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
30. Racevskis, J. 1990. Altered mouse mammary tumor virus transcription synthesis in T-cell lymphotna cells. J. Virol. 64:4043.
31. Moore, R., M. Dixon, R. Smith, G. Petters, and C. Dickson. 1987. Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J. Virol. 61:480.
32. Jarvis, C. D., R. N. Germain, G. L. Hager, M. Damschroder, and L. A. Matis. 1994. Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J. Immunol. 152:1032.
33. Wintersperger, S., B. Salmons, T. Miethke, V. Erfle, H. Wagner, and W. H. Gunzburg. 1995. Negative-acting factor and superantigen are separable activities of the mouse mammary tumor virus long terminal repeat. Proc. Natl. Acad. Sci. USA 92:2745.
34. Gunzburg, W. H., and B. Salmons. 1992. Factors controlling the expression of mouse mammary tumor virus. Biochem. J. 283:625.
35. Kwon, B. S., and S. M. Weissman. 1984. Mouse mammary tumor virus-related sequences in mouse lymphocytes are inducible by 12-o-tetradecanoylphorbol-13-acetate. J. Virol. 52:1000.
36. Sambasivarao, D., and V. Paetkau. 1996. Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with activation-dependent, T cell-specific transacting factors. J. Biol. Chem. 271:8942.
37. Reuss, F. U., and J. M. Coffin. 1995. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer. Proc. Natl. Acad. Sci. USA 92:9293.
38. Scherer, M. T., L. Ignatowicz, G. M. Winslow, J. W. Kappler, and P. Marrack. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell. Biol. 9:101.
39. Held, W., H. Acha-Orbea, H. R. MacDonald, and G. A. Waanders. 1996. Superantigens and retroviral infection: insights from mouse mammary tumor virus. Immunol. Today 15:184.
40. Golovkina, T. V., A. Chervonsky, J. A. Prescott, C. A. Janeway, Jr., and S. R. Ross. 1994. The mouse mammary tumor virus envelope gene product is required for superantigen presentation to T cells. J. Exp. Med. 179:439.
41. Secord, E. A., J. M. Edington, and G. J. Thorbecke. 1995. The Eμ-bcl-2 transgene enhances antigen-induced germinal center formation in both BALB/c and SJL mice but causes age-dependent germinal center hyperplasia only in the lymphoma-prone SJL strain. Am. J. Pathol. 147:422.
42. Giffin, W., H. Torrance, H. Saffran, H. L. Macleod, and R. J. G. Hache. 1994. Repression of mouse mammary tumor virus transcription by a transcription factor complex. J. Biol. Chem. 269:1449.